Stock-Based Compensation - Stock Appreciation Rights (Details)	12 Months Ended
	Dec. 31, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding, ending balance (in shares)	10,412,053
Stock Appreciation rights Weighted Average Exercise Price [Abstract]
Granted, Weighted average exercise price (in dollars per share) | $ / shares	$ 0.92
Stock Appreciation Rights (SARs)
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding, beginning balance (in shares)	7,138,335
Granted (in shares)	3,273,718
Vested (in shares)	4,092,224